PRAX EBITDA Growth

Praxis Precision Medicines Inc · EBITDA Growth

PRAX logo

PRAX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-35.18%
PRAX TTM EBITDA YoY % (-73.19% → -35.18%)
High-resolution chart · PNG

PRAX ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Praxis Precision Medicines Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-35.181%
-53.7676%
-66.133%
-81.3257%
-103.5635%
-70.0451%
-48.6577%
-10.3089%
20.9001%
30.962%
42.1288%
40.7451%
32.5932%
13.1336%
-27.0571%
-71.6603%
-118.6583%
-157.4399%
-169.5904%
-206.8474%
-177.0047%
-128.4104%
-73.1875%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.